Otonomy initiates phase 2 trial for AuriPro

San Diego's Otonomy Inc. (Nasdaq: OTIC) announced the enrollment of the first patients in a phase 2 clinical trial evaluating AuriPro for the treatment of patients with acute otitis externa, also known as swimmer's ear.


DJO Global subsidiary posts mixed results

San Diego-based DJO Global, Inc., a global provider of medical devices, has announced financial results for its public reporting subsidiary, DJO Finance LLC for the second quarter ended June 27, 2015.


American Specialty Health appoints Bonhomme as CTO

Jerome Bonhomme has joined American Specialty Health Inc. as chief technology officer.


On the Agenda: Entrepreneurs, business efficiency, tax credits on tap this week


San Diego's Banyan Biomarkers wins GE, NFL Head Health Challenge


Lpath gets FDA approval for clinical trial


Eli Lilly doubling size of SD biotech center


Trovagene public offering closed


Ignyta adds Parker in new chief commercial officer role


Regen trial shows therapy safe

Other Health Headlines:

The last-minute phone call that spurred Teva-Allergan deal

The chief executive officer of Teva Pharmaceuticals Industries Ltd., Erez Vigodman, was just hours away from increasing his hostile bid for Mylan Inc. when he got the news he’d waited months to hear. Brent Saunders, his counterpart at Botox-maker Allergan Plc, told him: Forget Mylan. Let’s do lunch.

American Specialty Health appoints Bonhomme as CTO

Jerome Bonhomme has joined American Specialty Health Inc. as chief technology officer.

Mega-health deals bloom in July; Anthem bids $48B for Cigna

NEW YORK — Anthem is buying rival Cigna for $48 billion in a deal that would create the nation's largest health insurer by enrollment, covering about 53 million U.S patients.

Contamination report on water aquifers withheld

California oil-and-gas regulators have refused for nearly a year to release findings of what they termed a “highest-priority” investigation of possible oilfield contamination into the water aquifers that serve millions of people in and around Los Angeles.

Biogen Data Complicates Quest to Slow Alzheimer’s Disease

(Bloomberg) -- Biogen Inc.’s experimental drug for Alzheimer’s disease failed to show a statistically significant cognitive benefit for patients on a closely watched dose, complicating the company’s quest to develop a treatment.

More Health News


In The News

Qualcomm will look at acquisition opportunities, and Fitbit is hiring engineers for a new R&D office space in San Diego. 

Health Videos

Interview with Shelley Lyford, Paul Downey

July 16, 2015 -- George Chamberlin speaks with Shelley Lyford, CEO of West Health, and Paul Downey, president and CEO of Serving Seniors, about participating in the Conference on Aging in Washington, D.C., and the various issues addressed.

Newsmaker Videos

Dick Crowley, Kitchell Contractors Inc.

Dick Crowley, Senior VP of Kitchell discusses the Largest Construction Project in San Diego County.

San Diego Stock Exchange

U.S. Markets

Index Value Change
{{name}} {{value}} {{daychange}}
Updated: -/-/---- -:-- --

Interactive Maps

Address, City, or Zip

Around Town



'Valley of the Sun'